Analysis of metabolites in serum and villous tissue of missed abortion patients based on targeted metabolomics - Report - MDSpire

Analysis of metabolites in serum and villous tissue of missed abortion patients based on targeted metabolomics

  • By

  • Huan Zhao

  • Wei Liu

  • Doudou Zhao

  • Mi Zhang

  • Muxi Yang

  • Li Shan

  • June 18, 2026

  • 0 min

Share

Clinical Report: Evaluation of Serum and Villous Tissue Metabolites in Missed Abortion

Overview

This study identifies distinct metabolic signatures associated with missed abortion, highlighting upregulated amino acid metabolism in serum and acylcarnitine disturbances in villous tissues. The findings suggest potential biomarkers for early pregnancy abnormalities.

Background

Missed abortion is a prevalent adverse pregnancy outcome, affecting approximately 15% of clinical pregnancies. Understanding the metabolic factors contributing to missed abortion is crucial for improving diagnostic and preventive strategies, as the causes remain unclear in many cases. This research leverages metabolomics to explore the relationship between metabolic disturbances and missed abortion.

Data Highlights

MetaboliteGroupChange
ORNMissed AbortionUpregulated
TYRMissed AbortionUpregulated
C10:1Missed AbortionUpregulated
C18Missed AbortionUpregulated
CITBothConsistently Upregulated

Key Findings

  • Distinct metabolic differences were observed in serum and villous tissues between missed abortion and control groups.
  • Serum metabolites showed upregulation of amino acids, particularly ORN and TYR, linked to missed abortion risk.
  • Villous tissues exhibited significant disturbances in acylcarnitine metabolism, notably C10:1 and C18.
  • No highly consistent differential metabolites were found between serum and villous tissues, except for CIT.
  • Combined panels of the top eight FDR-ranked metabolites demonstrated high AUCs for discrimination of missed abortion.

Clinical Implications

The identification of specific metabolites associated with missed abortion may aid in developing diagnostic tools and preventive strategies. Clinicians should consider these metabolic profiles when evaluating patients with early pregnancy complications.

Conclusion

This study enhances the understanding of the metabolic underpinnings of missed abortion, suggesting that targeted metabolomic profiling could serve as a valuable tool in clinical practice.

Related Resources & Content

  1. Archives of Toxicology, 2021 -- Metabolomic Profiling for Differentiating Phenotypes of Drug-Induced Liver Injury (DILI)
  2. Obesity Surgery, 2023 -- Clinical and Metabolic Biomarkers Linked to Type 2 Diabetes Remission Following Bariatric/Metabolic Surgery, Independent of Weight Loss
  3. Archives of Gynecology and Obstetrics, 2026 -- Transvaginal ultrasonographic characteristics of different types of residual pregnancy tissue in patients with incomplete medication abortion
  4. npj Digital Medicine, 2025 -- Metabolomic Profiling in Non-Invasive Liquid Biopsy Enhances Diagnosis and Early Detection of Severe Acute Pancreatitis
  5. ACR Appropriateness Criteria® First Trimester Vaginal Bleeding: 2025 Update
  6. American Society for Reproductive Medicine, 2026 -- Recurrent pregnancy loss: a committee opinion
  7. ScienceDirect -- The metabolic landscape of the maternal-fetal interface in missed miscarriage: a cross-sectional pilot multiomics study
  8. ACR Appropriateness Criteria® First Trimester Vaginal Bleeding: 2025 Update
  9. Recurrent pregnancy loss: a committee opinion (2026) | American Society for Reproductive Medicine | ASRM
  10. The metabolic landscape of the maternal-fetal interface in missed miscarriage: a cross-sectional pilot multiomics study - ScienceDirect

Original Source(s)

Related Content